作者:Mohamed Jawed Ahsan、Rachana Meena、Swati Dubey、Vasim Khan、Sunita Manda、Surender Singh Jadav、Piush Sharma、Mohammed H. Geesi、Mohd. Zaheen Hassan、Mohammad Afroz Bakht、Yassine Riadi、Md. Habban Akhter、Salahuddin、Rambabu Gundla
DOI:10.1007/s00044-017-2109-1
日期:2018.3
In continuation of our research to explore new antiproliferative agents, we report herein the synthesis and antiproliferative activity of two new series of N-(substituted phenyl)-5-aryl-1,3,4-oxadiazol-2-amine (4a–j) and N-[5-aryl-1,3,4-oxadiazol-2-yl]methyl}-substituted aniline (4k–t) analogs. The antiproliferative activity of fifteen compounds (4a–h, and 4n) was tested against nine different panels
在继续探索新的抗增殖剂的研究工作中,我们在此报告了两个新系列的N-(取代的苯基)-5-芳基-1,3,4-恶二唑-2-胺(4a – j)和N -[5-芳基-1,3,4-恶二唑-2-基]甲基}取代的苯胺(4k – t)类似物。测试了15种化合物(4a – h和4n)的抗增殖活性,针对近60种NCI人类癌细胞系的9种不同成分。N-(2-甲氧基苯基)-5-(4-氯苯基)-1,3,4-恶二唑-2-胺(4b)和4- 5-[(2-甲氧基苯基)氨基] -1,3,4-恶二唑-2-基}酚(4c)在该系列中显示出最大的抗增殖活性,平均增长百分比(GPs)为45.20和56.73。化合物4b在近47个癌细胞系上显示出显着的百分比生长抑制(GIs),并且发现对HL-60(TB),MDA-MB-435,OVCAR-3和K-562具有较高的GIs( GIs分别为109.62、105.90、91.94和88.30。同